N/A
Completed N=338
A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients
End Stage Renal Failure on Dialysis · Complication of Dialysis · Blood Coagulation Disorders
Source: ClinicalTrials.gov NCT02086682 ↗
Enrolled (actual)
338
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcomePrimary: Clotting of Extracorporeal Dialysis Circuit — 30; 33 Clotting events — p=0.79
Summary
The introduction of unfractionated heparin (UFH), which prevents clotting of the extracorporal circuit, was one of the key advances that led to the rapid development and expansion of hemodialysis services. However, anticoagulation during hemodialysis of the patient at high risk for bleeding remains a frequently encountered problem in both inpatient and outpatient dialysis practice.
Streamline bloodlines are designed to eliminate blood-air contact. This is thought to help reduce heparin use and decrease clotting rates. The goal of this study was to prospectively examine impact of the Streamline airless blood tubing set, in an inpatient setting, on dialysis circuit clotting rates, anticoagulation use, and dialysis efficiency.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clotting of Extracorporeal Dialysis Circuit |
30; 33 | 0.79 |
Eligibility Criteria
Inclusion Criteria
- All adult non-pregnant patients requiring inpatient hemodialysis at our center during the recruitment period until the target sample of dialysis sessions (n=1200) was reached.
Exclusion Criteria
- Pregnant females
- Children
Data sourced from ClinicalTrials.gov (NCT02086682). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.